Clinical Trial Update: ST266 in UV-induced Inflammation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of ST266 for UV-induced skin inflammation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Burns

Drugs mentioned

• ST266

Snippet

Sponsor: Noveome Biotherapeutics, formerly Stemnion | Conditions: Skin Burns | Phase 2 | Status: COMPLETED